| Article
The search for a new molecule in the face of the opioid crisis may have taken a major step forward with the recent discovery of a chemical compound, AT-121, that provides analgesia without addictive potential. Mei-Chuan Ko, PhD, professor of physiology and pharmacology at the School of Medicine...
| Article
New research led by a team from Binghamton University, State University at New York, concludes that single-step nasal spray delivery of naloxone is the easiest and most successful route of administration for members of the general community. Naloxone, also known by the brand name Narcan®, can be...
| Article
A new report released by the National Drug Early Warning System, Office of National Drug Control Policy, emphasizes the complexity of assessing and treating drug overdose patients who present at hospital emergency departments. The report distills findings from a study begun in 2016 of the illicit...
| Article
New research from Johns Hopkins Bloomberg School of Public Health suggests that the effort to establish harm reduction resources to address the opioid abuse crisis could be assisted by changing the name of these locations from “safe consumption sites” to “overdose prevention sites.” A survey of a...
| Article
Younger patients who filled a prescription for opioids when undergoing wisdom tooth extraction were 2.7 times more likely to fill at least 2 more prescriptions in the following year, according to findings from a new study conducted in association with the Michigan Opioid Prescribing and Engagement...
| Article
A new retrospective study conducted by researchers from University of Iowa Hospitals and Clinics, Iowa City reports that preoperative use of opioids is a significant predictor of continued postoperative opioid use in patients who undergo lumbar spinal fusion surgery. Study author Andrew Pugely, MD...
| Article
Findings from a recent study suggest that rethinking the delivery mechanism for buprenorphine may enhance its effectiveness in treating opioid use disorder (OUD), now estimated to affect some 2.6 million American patients. The medication is typically delivered sublingually in the form of tablets or...
| Podcast
Overdose--a small word that packs a major punch, and a big reason for many recent legal regulatory changes in controlled substance prescribing and pain management. Too many physicians and allied healthcare practitioners are caught unawares by the legal issues surrounding overdose events, fatal and...
| Article
Although the CDC has issued recommendations against taking opioids with benzodiazepines, almost 25% of Medicare patients who are prescribed opioids are also getting prescriptions for benzodiazepines. Now, results from a study conducted at the University of Pittsburg School of Pharmacy confirms the...
| Article
Practitioners need to understand that there are steps that they should be taking to minimize the potential of a bad legal outcome in the event of an investigation involving an overdose.
The liability for an overdose event tracks back to the practitioner’s adherence to licensing board requirements...